ABEO
Price
$5.42
Change
-$0.06 (-1.09%)
Updated
May 9, 12:13 PM (EDT)
Capitalization
267.91M
101 days until earnings call
RCKT
Price
$6.93
Change
-$0.11 (-1.56%)
Updated
May 9, 02:04 PM (EDT)
Capitalization
715.46M
94 days until earnings call
Ad is loading...

ABEO vs RCKT

Header iconABEO vs RCKT Comparison
Open Charts ABEO vs RCKTBanner chart's image
Abeona Therapeutics
Price$5.42
Change-$0.06 (-1.09%)
Volume$200
Capitalization267.91M
Rocket Pharmaceuticals
Price$6.93
Change-$0.11 (-1.56%)
Volume$1.67K
Capitalization715.46M
ABEO vs RCKT Comparison Chart
Loading...
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABEO vs. RCKT commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ABEO: $5.49 vs. RCKT: $7.04)
Brand notoriety: ABEO and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABEO: 86% vs. RCKT: 93%
Market capitalization -- ABEO: $267.91M vs. RCKT: $715.46M
ABEO [@Biotechnology] is valued at $267.91M. RCKT’s [@Biotechnology] market capitalization is $715.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABEO’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • ABEO’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABEO and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABEO’s TA Score shows that 7 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).

  • ABEO’s TA Score: 7 bullish, 3 bearish.
  • RCKT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ABEO is a better buy in the short-term than RCKT.

Price Growth

ABEO (@Biotechnology) experienced а -20.09% price change this week, while RCKT (@Biotechnology) price change was -10.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.07%. For the same industry, the average monthly price growth was +11.10%, and the average quarterly price growth was -13.37%.

Reported Earning Dates

ABEO is expected to report earnings on Aug 18, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-5.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($715M) has a higher market cap than ABEO($268M). ABEO YTD gains are higher at: -1.436 vs. RCKT (-43.994). ABEO has higher annual earnings (EBITDA): -64.95M vs. RCKT (-247.48M). RCKT has more cash in the bank: 372M vs. ABEO (110M). ABEO has less debt than RCKT: ABEO (23.1M) vs RCKT (25.5M). ABEO (0) and RCKT (0) have equivalent revenues.
ABEORCKTABEO / RCKT
Capitalization268M715M37%
EBITDA-64.95M-247.48M26%
Gain YTD-1.436-43.9943%
P/E RatioN/AN/A-
Revenue00-
Total Cash110M372M30%
Total Debt23.1M25.5M91%
FUNDAMENTALS RATINGS
ABEO vs RCKT: Fundamental Ratings
ABEO
RCKT
OUTLOOK RATING
1..100
6918
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
5064
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
2150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for ABEO (62) in the Pharmaceuticals Generic industry. This means that RCKT’s stock grew somewhat faster than ABEO’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ABEO (100) in the Pharmaceuticals Generic industry. This means that RCKT’s stock grew similarly to ABEO’s over the last 12 months.

RCKT's SMR Rating (93) in the Biotechnology industry is in the same range as ABEO (97) in the Pharmaceuticals Generic industry. This means that RCKT’s stock grew similarly to ABEO’s over the last 12 months.

ABEO's Price Growth Rating (50) in the Pharmaceuticals Generic industry is in the same range as RCKT (64) in the Biotechnology industry. This means that ABEO’s stock grew similarly to RCKT’s over the last 12 months.

ABEO's P/E Growth Rating (100) in the Pharmaceuticals Generic industry is in the same range as RCKT (100) in the Biotechnology industry. This means that ABEO’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABEORCKT
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TLGAX12.43N/A
N/A
Timothy Plan Large/Mid Cap Growth A
USLIX70.68N/A
N/A
JHancock U.S. Global Leaders Growth I
HRTVX44.13N/A
N/A
Heartland Value Investor
OMSIX55.61N/A
N/A
Invesco Main Street R6
MDOBX10.28N/A
N/A
Morgan Stanley Developing Opportunity C

ABEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with ELVN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
+4.27%
ELVN - ABEO
47%
Loosely correlated
+1.97%
ERAS - ABEO
43%
Loosely correlated
+13.47%
APGE - ABEO
43%
Loosely correlated
+7.29%
RGLS - ABEO
42%
Loosely correlated
N/A
RCKT - ABEO
42%
Loosely correlated
+11.57%
More